Precision gene-editing for neurodegenerative diseases

Targeting prion disease reversal via CRISPR-based gene editing and protein misfolding inhibitors

prion disease CRISPR protein misfolding neurodegenerative therapy

Inflammasome inhibition strategies for chronic neurodegenerative disease intervention using art-inspired biomolecules

neuroinflammation biomimicry drug design neurodegenerative diseases artistic biology

Across axonal propagation delays, measuring neural synchronization in neurodegenerative diseases

axonal delay neurodegeneration neural synchronization action potential tauopathy

Targeting protein misfolding in neurodegenerative diseases via photoredox chemistry

protein misfolding photoredox neurodegeneration tauopathy alpha-synuclein

Through inflammasome inhibition for targeted neurodegenerative disease therapy

inflammasome neurodegeneration neuroinflammation Alzheimer's disease therapeutic targets

Targeting protein misfolding through mechanochemical reactions for neurodegenerative diseases

protein misfolding mechanochemistry neurodegenerative diseases Alzheimer's Parkinson's

Using explainability through disentanglement in deep learning for neurodegenerative disease prediction

explainable AI disentanglement neurodegenerative diseases deep learning medical diagnostics

Breakthroughs in Alzheimer's treatment via century-long clinical trials and multi-omics integration

Alzheimer's disease century-long trials multi-omics neurodegenerative treatments clinical research

Tracking protein folding intermediates through time-resolved cryo-electron microscopy

protein folding cryo-EM structural biology neurodegenerative diseases molecular dynamics

Across axonal propagation delays in neurodegenerative disease models

axonal delays neurodegeneration biomarkers Alzheimer's disease neural signaling

Targeting 2025 regulatory approval for CRISPR-based neurodegenerative disease therapies

CRISPR neurodegenerative diseases clinical trials gene editing regulatory approval

Optimizing viral vector engineering for targeted gene therapy in neurodegenerative diseases

AAV vectors blood-brain barrier Parkinson’s disease capsid engineering gene delivery